Teamit is proud to celebrate its long-standing contribution to VAC4EU, the international association driving vaccine monitoring and real-world evidence (RWE) generation across Europe, following the 5th General Assembly Meeting held this week in Valencia.
A key highlight from the meeting was the re-election of Eva Molero, Teamit CEO, to the VAC4EU Executive Board for another three years. This renewed mandate reflects the shared vision of Teamit and VAC4EU since its inception.
I am honoured and excited to contribute to the VAC4EU strategy in the coming years. In the post-covid vaccine wave we continue committed to serve public health and hence are expanding the VAC4EU activities to other vaccines
Eva Molero, Teamit CEO & VAC4EU Executive Board member
Over the last five years years, Teamit has played an active role in advancing VAC4EU’s mission to build a solid infrastructure for post-marketing vaccine surveillance across Europe. This partnership has evolved to encompass a range of strategic collaborations in business development and communications helping to grow VAC4EU’s network and visibility and contributing to more RWE projects.
Alongside other executive board members UMCU, ARS Toscana, University of Milan, DSRU, PHARMO, University of Padova, Teamit and VAC4EU have worked to strengthen stakeholder engagement, foster collaborations across sectors, and promote the value of real-world data in advancing public health. Looking ahead, Teamit remains committed to building on these shared objectives to create new opportunities for innovation and impact.
